BK

Brijendra Kumar Sood

Active Director Designated Partner DIN 06857041
DIN 06857041 First appointment Jul 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Brijendra Kumar Sood

Data last updated:

Brijendra Kumar Sood is a Designated Partner at Rejiva Therapeutics Llp (since 2016). The company operates in Healthcare.

DIN 06857041
Primary Designation Designated Partner
Industry Healthcare
First Appointment 03 Jul 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Jul 20162016Active

Board colleagues of Brijendra Kumar Sood

NameDINCompanyDesignation
Ankur Sood07519348Rejiva Therapeutics LlpDesignated Partner
Pragya Mishra07519350Rejiva Therapeutics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rejiva Therapeutics Llp
Premium access

Shareholding and investment profile for Brijendra Kumar Sood

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brijendra Kumar Sood

Brijendra Kumar Sood currently holds 1 directorship: Rejiva Therapeutics Llp (Designated Partner, since 03 Jul 2016).

Brijendra Kumar Sood was first appointed on 03 Jul 2016 as Designated Partner at Rejiva Therapeutics Llp.

The current boards of Brijendra Kumar Sood's companies include Ankur Sood (Rejiva Therapeutics Llp), Pragya Mishra (Rejiva Therapeutics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available